Table 1

Patient demographics

Patient no.

Age (years)

Tumor size (mm)

Node status

ER status

PgR status

Clinical response

Pathological finding (after chemotherapy)


1

42

7

+

+

n/a

CR

No surgery

2

37

50

+

+

n/a

MRD

No surgery

3

50

19

+

+

n/a

MRD

DCIS only

4

56

24

-

-

n/a

MRD

No surgery

5

56

50

+

-

n/a

MRD

DCIS only

6

48

50

+

-

n/a

SD

RID

7

64

40

+

-

-

PR

RID

8

47

30

-

+

n/a

SD

RID

9

51

50

-

+

n/a

PR

RID

10

67

30

-

-

-

SD

RID


CR, complete clinical response (no residual palpable disease); ER, estrogen receptor; MRD, minimal residual disease (residual palpable irregularity that was too small to be measured); n/a, not available; PgR, progestrogen receptor; PR, partial response (more than 50% reduction in bidimensional measurement); SD, stable disease (between 50% reduction and 25% increase in bidimensional measurement); RID, residual invasive disease; DCIS, ductal carcinoma in situ.

Sotiriou et al. Breast Cancer Res 2002 4:R3   doi:10.1186/bcr433

Open Data